KV11.1 channel–specific antibodies, such as the single-chain variable fragment (scFv), anti-Kv11.1 ScFv, are more relevant for cancer diagnosis, rather than for cancer treatment (Duranti et al., 2018). Here, KCNH2 is linked to cancer.